SUVRETTA CAPITAL MANAGEMENT, LLC - Q3 2023 holdings

Add to watchlist

$1.85 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 87 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 35.5% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
RPRX BuyROYALTY PHARMA PLC$111,158,519
+18.7%
4,095,745
+34.4%
6.01%
+19.9%
BuyBIOHAVEN LTD$104,185,656
+12.6%
4,005,600
+3.6%
5.63%
+13.8%
BuyARCELLX INC$102,974,416
+14.3%
2,869,967
+0.8%
5.56%
+15.6%
INSM BuyINSMED INC$87,019,934
+32.6%
3,446,334
+10.8%
4.70%
+34.0%
FB BuyMETA PLATFORMS INCcl a$84,252,435
+16.9%
280,645
+11.7%
4.55%
+18.1%
AMZN BuyAMAZON COM INC$78,746,899
+84.2%
619,469
+88.9%
4.26%
+86.1%
AMD BuyADVANCED MICRO DEVICES INC$71,615,158
+69.6%
696,510
+87.9%
3.87%
+71.5%
ITCI BuyINTRA-CELLULAR THERAPIES INC$71,355,434
-6.0%
1,369,849
+14.3%
3.86%
-5.0%
MSFT NewMICROSOFT CORP$68,887,178–218,170
+100.0%
3.72%–
KURA BuyKURA ONCOLOGY INC$66,902,906
-10.0%
7,335,845
+4.4%
3.62%
-9.1%
WYNN BuyWYNN RESORTS LTD$42,513,036
+34.8%
460,048
+54.0%
2.30%
+36.2%
BuyMARINUS PHARMACEUTICALS INC$41,899,783
-4.9%
5,204,942
+28.3%
2.26%
-3.9%
ETNB Buy89BIO INC$41,601,598
-8.3%
2,694,404
+12.6%
2.25%
-7.3%
BuyGENERAL ELECTRIC CO$38,799,623
+83.3%
350,969
+82.1%
2.10%
+85.2%
NVDA BuyNVIDIA CORPORATION$38,517,495
+17.5%
88,548
+14.3%
2.08%
+18.7%
CMG NewCHIPOTLE MEXICAN GRILL INC$37,369,332–20,400
+100.0%
2.02%–
GPN BuyGLOBAL PMTS INC$32,827,070
+18.5%
284,488
+1.2%
1.77%
+19.8%
TERN BuyTERNS PHARMACEUTICALS INC$30,390,807
-37.6%
6,041,910
+8.6%
1.64%
-36.9%
COGT BuyCOGENT BIOSCIENCES INC$29,769,675
+13.3%
3,053,300
+37.6%
1.61%
+14.5%
EYPT BuyEYEPOINT PHARMACEUTICALS INC$27,902,255
-6.3%
3,492,147
+2.0%
1.51%
-5.3%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$24,222,713
-3.0%
679,459
+25.5%
1.31%
-2.0%
KALV BuyKALVISTA PHARMACEUTICALS INC$23,312,795
+27.3%
2,420,851
+19.0%
1.26%
+28.7%
LLY NewELI LILLY & CO$21,001,783–39,100
+100.0%
1.14%–
BCYC NewBICYCLE THERAPEUTICS PLCsponsored ads$20,310,508–1,010,976
+100.0%
1.10%–
BSX BuyBOSTON SCIENTIFIC CORP$18,677,525
+1793.0%
353,741
+1839.3%
1.01%
+1803.8%
BuyPROKIDNEY CORP$17,714,721
-50.4%
3,867,843
+21.1%
0.96%
-49.9%
WFC BuyWELLS FARGO CO NEW$17,508,755
-3.1%
428,506
+1.2%
0.95%
-2.1%
NewAPOLLO GLOBAL MGMT INC$17,224,944–191,900
+100.0%
0.93%–
MCK BuyMCKESSON CORP$16,324,269
+1987.6%
37,540
+1951.4%
0.88%
+2000.0%
JNJ BuyJOHNSON & JOHNSON$14,032,608
+2.4%
90,097
+8.8%
0.76%
+3.4%
UNH BuyUNITEDHEALTH GROUP INC$13,725,564
+122.7%
27,223
+112.3%
0.74%
+124.8%
SANA BuySANA BIOTECHNOLOGY INC$11,469,534
-9.0%
2,963,704
+40.2%
0.62%
-8.0%
RCUS NewARCUS BIOSCIENCES INC$10,717,927–597,099
+100.0%
0.58%–
ANAB NewANAPTYSBIO INC$8,610,832–479,445
+100.0%
0.46%–
ARQT BuyARCUTIS BIOTHERAPEUTICS INC$6,028,055
-27.5%
1,135,227
+30.1%
0.33%
-26.7%
ELAN BuyELANCO ANIMAL HEALTH INC$6,030,260
+37.2%
536,500
+22.8%
0.33%
+38.7%
TEVA NewTEVA PHARMACEUTICAL INDS LTDsponsored ads$5,073,480–497,400
+100.0%
0.27%–
AZN BuyASTRAZENECA PLCsponsored adr$4,773,583
+85.8%
70,490
+96.4%
0.26%
+88.3%
NewKENVUE INC$3,445,648–171,596
+100.0%
0.19%–
NewAEGLEA BIOTHERAPEUTICS INC$1,989,339–162,395
+100.0%
0.11%–
PTGX BuyPROTAGONIST THERAPEUTICS INC$1,806,577
-19.4%
108,308
+33.5%
0.10%
-18.3%
NewBENITEC BIOPHARMA INC$617,092–204,220
+100.0%
0.03%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
32024-05-02
SC 13D2024-04-29
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

All filings

View complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings

CSVXLS